Pégurier C, Collart P, Danhaive P, Defays S, Gillard M, Gilson F, Kogej T, Pasau P, Van Houtvin N, Van Thuyne M, van Keulen B. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
Bioorg Med Chem Lett 2007;
17:4228-31. [PMID:
17532633 DOI:
10.1016/j.bmcl.2007.05.035]
[Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2007] [Revised: 05/09/2007] [Accepted: 05/11/2007] [Indexed: 11/24/2022]
Abstract
The discovery and optimization of a novel class of potent CCR3 antagonists is described. Details of synthesis and SAR are given together with some ADME properties of selected compounds. An optimal balance between activities, physicochemical properties, and in vitro metabolic stability was reached by the proper choice of substituents.
Collapse